lilly retatrutide trial Eli just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Eli Lilly's tirzepatide showed positive

Unlike harsh laxatives or fiber overload supplements, ColonBroom is praised for its balanced, daily-use design

Louis found that GLP-1 medications were associated with lower risks of developing substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other substances

Dose level matters because most programs price by dose tier

Compared to popular GLP-1RAs like semaglutide, orforglipron does not require injection or an absorption enhancer with fasting to achieve exposure, and it can be taken without water or food restrictions, according to Phase 1 pharmacokinetic data

The ingredients in Activate, particularly the combination of hibiscus and lemon verbena polyphenols, have been shown in clinical studies to modestly increase GLP-1 levels (12-22% above baseline)

The manufacturer also offers a Home Delivery Program at $99/month or less with free shipping